Latest Breaking News On - Toshiichiro ito - Page 1 : comparemela.com

iPS cells are moving from clinical trialsーeye disease, Parkinson’s disease, heart failure, cancer, spinal cord injuriesーto the stage of practical application.

United statesShinya yamanakaToshiichiro itoSankei shimbunJun takahashiPs cell research foundationPs cell researchJapan society for regenerative medicineSchool of osaka city universityKyoto university ciKyoto universityPs cell research instituteKyoto university school of medicineKobe university school of medicineSalk institute for biologicalKyoto university graduate school